Clinical Trial Update: Hydroxypropylmethylcellulose 0.3% and Sodium Hyaluronate 0.18% for Ocular Surface Disease in Glaucoma [NA]

View source ↗

Summary

This clinical trial examines a combination of hydroxypropylmethylcellulose 0.3% and sodium hyaluronate 0.18% for ocular surface disease in glaucoma, with status…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma
• Ocular Surface Disease

Drugs mentioned

• Hydroxypropylmethylcellulose 0.3% (Hydroxypropylmethylcellulose)
• Sodium Hyaluronate 0.18% (Sodium Hyaluronate)

Snippet

Sponsor: Mahidol University | Conditions: Ocular Surface Disease, Glaucoma | NA | Status: UNKNOWN